Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 2, 2015 (Event Date: February 3, 2015)
Context: The Company entered into a Share Purchase Agreement for a private placement of common stock with certain accredited investors.
Key Financial Metrics
This filing reports on a specific financing transaction rather than periodic operating results. Key transaction metrics include:
- Shares Issued: 1,658,822 shares of Common Stock.
- Price Per Share: $4.25.
- Aggregate Purchase Price: Approximately $7,050,000.
- Revenue/Profit/Cash Flow: The filing text does not provide clear values for operating revenue, net income, operating cash flow, or margins.
- Debt/Liquidity: The filing text does not provide clear values for total debt or current liquidity positions outside of the proceeds from this transaction.
Material Changes
The primary material change is the execution of a private placement to raise capital. This follows an amendment to a prior Share Purchase Agreement dated January 9, 2015. The Company is obligated to file a registration statement with the SEC to register the shares for resale.
Guidance, Outlook, and Risks
- Transaction Status: The Company is obligated to sell the shares and investors are obligated to purchase them. The full terms will be detailed in a subsequent Form 8-K/A upon receipt of funds.
- Regulatory Compliance: The shares were offered under Section 4(2) of the Securities Act and Rule 506 of Regulation D. They are unregistered and cannot be resold in the U.S. absent registration or an exemption.
- Outlook: No specific operational guidance or future financial projections are provided in this text.
Investor Verification Checklist
- Verify the receipt of the $7,050,000 purchase price by monitoring the upcoming Form 8-K/A.
- Review the Registration Rights Agreement to understand the timeline for the resale registration statement.
- Confirm the identity of the accredited investors and any specific covenants attached to the purchase agreement.
- Check for any subsequent filings regarding the use of proceeds from this private placement.